Članki z zahtevami za javni dostop - Marc S. SabatineVeč o tem
Ni na voljo nikjer: 18
Pregled
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset …
MS Sabatine, LA Leiter, SD Wiviott, RP Giugliano, P Deedwania, ...
The lancet Diabetes & endocrinology 5 (12), 941-950, 2017
Zahteve: National Institute for Health Research, UK
Pregled
Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
MS Sabatine, RP Giugliano, A Keech, N Honarpour, H Wang, T Liu, ...
American heart journal 173, 94-101, 2016
Zahteve: National Institute for Health Research, UK
Pregled
Design and rationale for the prevention of cardiovascular events in patients with prior heart attack using ticagrelor compared to placebo on a background of aspirin …
MP Bonaca, DL Bhatt, E Braunwald, M Cohen, PG Steg, RF Storey, ...
American heart journal 167 (4), 437-444. e5, 2014
Zahteve: US National Institutes of Health
Pregled
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or …
SR Wilson, MS Sabatine, SD Wiviott, KK Ray, JA De Lemos, S Zhou, ...
American heart journal 161 (6), 1147-1155. e1, 2011
Zahteve: US National Institutes of Health
Pregled
Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial
CT Ruff, M Baron, KA Im, ML O’Donoghue, FT Fiedorek, MS Sabatine
Nature Medicine 28 (1), 89-95, 2022
Zahteve: US National Institutes of Health
Pregled
Opportunities and challenges in mendelian randomization studies to guide trial design
CJ O’Donnell, MS Sabatine
JAMA cardiology 3 (10), 967-967, 2018
Zahteve: UK Medical Research Council
Pregled
CYP2C19 genotype and cardiovascular events
JL Mega, EJ Topol, MS Sabatine
Jama 307 (14), 1482-1485, 2012
Zahteve: US National Institutes of Health
Pregled
Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel
ET Carreras, W Hochholzer, AL Frelinger III, F Nordio, ML O’Donoghue, ...
Thrombosis and haemostasis 116 (07), 69-77, 2016
Zahteve: US National Institutes of Health
Pregled
Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to …
PG Steg, SR Mehta, CV Pollack Jr, C Bode, C Gaudin, K Fanouillere, ...
American heart journal 164 (6), 817-824. e13, 2012
Zahteve: National Institute of Health and Medical Research, France
Pregled
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36
MP Bonaca, RG O’Malley, SA Murphy, P Jarolim, MJ Conrad, ...
European Heart Journal: Acute Cardiovascular Care 4 (5), 431-440, 2015
Zahteve: US National Institutes of Health
Pregled
Prognostic importance of anaemia in patients with acute pulmonary embolism
J Donzé, J Labarère, M Méan, D Jiménez, D Aujesky
Thrombosis and haemostasis 106 (08), 289-295, 2011
Zahteve: Swiss National Science Foundation, US National Institutes of Health
Pregled
MicroRNA-375 repression of Kruppel-like factor 5 improves angiogenesis in diabetic critical limb ischemia
MG McCoy, A Jamaiyar, G Sausen, HS Cheng, D Pérez-Cremades, ...
Angiogenesis 26 (1), 107-127, 2023
Zahteve: US National Institutes of Health, American Heart Association
Pregled
Per-particle cardiovascular risk of lipoprotein (a) vs non-Lp (a) apolipoprotein B-containing lipoproteins
NA Marston, GEM Melloni, SA Murphy, J Morze, FK Kamanu, PT Ellinor, ...
Journal of the American College of Cardiology 83 (3), 470-472, 2024
Zahteve: US National Institutes of Health
Pregled
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic …
WAE Parker, DJ Angiolillo, F Rollini, F Franchi, MP Bonaca, DL Bhatt, ...
Vascular Pharmacology 149, 107145, 2023
Zahteve: US National Institutes of Health, British Heart Foundation, National …
Pregled
Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment
M Yang, T Kondo, IS Anand, RA de Boer, RT Campbell, L Køber, ...
European journal of heart failure, 2024
Zahteve: British Heart Foundation
Pregled
New antibody assays for cardiovascular disease: future tools for the clinical chemist?
RE Gerszten, M Sabatine, TJ Wang
Clinical chemistry 55 (3), 404-406, 2009
Zahteve: US National Institutes of Health
Pregled
Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk
SH Choi, SJ Jurgens, L Xiao, MC Hill, CM Haggerty, G Sveinbjörnsson, ...
Nature Genetics, 1-15, 2025
Zahteve: Knut and Alice Wallenberg Foundation, European Commission
Pregled
Clopidogrel Dosing Based on Genotype—Reply
JL Mega, MS Sabatine
JAMA 307 (10), 1024-1025, 2012
Zahteve: US National Institutes of Health
Na voljo nekje: 237
Pregled
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Zahteve: US National Institutes of Health, American Heart Association
Pregled
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
Zahteve: British Heart Foundation, UK Medical Research Council, National Institute …
Podatke o objavi in financiranju samodejno določi računalniški program